Manifold Bio
Allston, MA · Biotechnology · 35 employees
Manifold Bio is a platform therapeutics company building the first AI-guided direct-to-vivo discovery platform to accelerate the development of tissue-targeted medicines. By testing thousands of molecules simultaneously in vivo, Manifold uncovers delivery strategies that unlock new therapeutic possibilities across neurodegenerative, metabolic, and other major diseases. Its mDesign engine integrate
Funding history
- Venture - Series Unknown — $32.8M — Dec 2024
- Venture - Series Unknown — $40.0M — Jun 2022
- Venture - Series Unknown — $5.4M — Aug 2020
Recent signals
- Dec 15, 2025: Manifold Bio Appoints Paula Cobb as Chief Operating Officer
- Dec 03, 2024: Raised $32.8M in Venture - Series Unknown
- Jun 13, 2022: Raised $40.0M in Venture - Series Unknown
- Aug 13, 2020: Raised $5.4M in Venture - Series Unknown
See plans & pricing → Track Manifold Bio’s funding, hiring, and signals — with verified contacts — on Fundz.